Izidore Lossos MD

PubMed

• Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.
  Yucai Wang, Melissa C Larson, Steven R Hwang, Diego Villa, Laveniya Kugathasan
  Blood Advances. 2026-02-24
• Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study.
  Jia Ruan, Zhengming Chen, Melissa C Larson, N Nora Bennani, Pamela Blair Allen
  Blood Advances. 2026-02-18
• 1 citations
  FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.
  Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly, Christopher R Flowers, Diego Villa
  Journal of Clinical Oncology. 2026-01-10

Abstracts/Posters

• R-MACLO-IVAM Is an Effective Regimen to Induce Long Term Remission in Untreated Mantle Cell Lymphoma
  Izidore S. Lossos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analys...
  Izidore S. Lossos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Izidore S. Lossos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Atezolizumab in Combination with Obinutuzumab and Lenalidomide Demonstrates Favorable Activity and Manageable Toxicity in Patients with Relapsed/Refractory Follicular ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Genetic Analysis of Plasmablastic Lymphomas in HIV (+) Patients Reveals Novel Driver Regulators of the Noncanonical NF-Κb Pathway 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018